PLK Polo-like kinase

Inhibitors

Cat.No.	Name	Information
M1672	BI 2536	BI 2536 is a novel, highly selective, potent dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively.
M13721	TAK-960 dihydrochloride	TAK-960 dihydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC₅₀ of 0.8 nM.
M13720	Rigosertib sodium	Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.
M13719	Rigosertib	Rigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.
M13718	Onvansertib	NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an IC50 of 2 nM.
M13717	HMN-214	HMN-214, an orally bioavailable prodrug of HMN-176, is an inhibitor of polo-like kinase-1 (plk1), with antitumor activity.
M9307	TC-S 7005	TC-S 7005 is a potent and selective polo-like kinase 2 (PLK2) inhibitor (IC50 = 4 nM).
M9250	HMN-176	HMN-176 inhibits mitosis, interfering with polo-like kinase-1 (plk1), without significant effect on tubulin polymerization.
M8519	Mps1-IN-2	Mps1-IN-2 is a potent and selective inhibitor of Mps1 kinase.
M7559	ON1231320	ON1231320, also known as GBO-006, is a Polo-like kinase 2 (PLK2) inhibitor. In vitro testing revealed that ON1231320 is a selective inhibitor of PLK2 with no inhibitory activity against PLK1, PLK3 and PLK4.
M7271	SBE13 hydrochloride	SBE13 hydrochloride is a potent and selective PLK1 inhibitor.
M3293	HMN-214	HMN-214 is a procompound of HMN-176, which alters the cellular spatial orientation of Plk1.
M3198	TAK-960	TAK-960 is a novel, potent and selective Plk1 inhibitor with IC50 of 8 nM.
M2983	Ro3280	RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM.
M2860	MLN0905	MLN0905 is a potent inhibitor of PLK1 with IC50 of 2 nM.
M2741	GW843682X	GW 843682X is a PLK inhibitor for PLK1 and PLK3 with IC50 of 2.2 nM and 9.1 nM, respectively.
M2211	Rigosertib sodium	Rigosertib sodium is a dual non-ATP inhibitor of polo-like kinase 1 (Plk1) and phosphoinositide 3-kinase pathways (PI3K).
M1719	GSK461364	GSK461364 is a potent and selective small molecule inhibitor of Polo-like kinase 1 (PLK1) with a Ki of 2.2 nM.
M1678	BI 6727	BI 6727 (Volasertib) is a small highly potent Polo-like kinase inhibitor (Plk1) with an IC50 of 0 .87 nM.
M1672	BI 2536	BI 2536 is a novel, highly selective, potent dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively.

Signaling Pathways

Product Type

PLK Polo-like kinase

Get to Know Us

Customer Support

Resources

Contact Us